TABLE 1.
Characteristics of the participants.
| Characteristic | N (%) |
|---|---|
| Total, n | 454 |
| Age, mean (SD), years | 56.9 (11.3) |
| Gender | |
| Female | 190 (41.9) |
| Male | 264 (58.1) |
| Marital status | |
| Married | 434 (95.6) |
| Single, divorced or windowed | 20 (4.4) |
| Education | |
| ≤9 years | 227 (50.0) |
| ≥10 years | 227 (50.0) |
| ECOG PS | |
| 0 | 140 (30.8) |
| 1 | 228 (50.2) |
| 2 | 86 (18.9) |
| Disease stage | |
| No evidence of disease | 20 (4.4) |
| Locoregional | 180 (39.6) |
| Locoregional plus metastatic | 11 (2.4) |
| Metastatic | 243 (53.5) |
| Disease status | |
| Complete remission | 16 (3.5) |
| Partial remission | 104 (22.9) |
| Stable disease | 201 (44.3) |
| Progressive disease | 93 (20.5) |
| Unclear | 40 (8.8) |
| Prior chemotherapy | |
| No | 198 (43.6) |
| Yes | 256 (56.4) |
| Prior radiotherapy | |
| No | 397 (87.4) |
| Yes | 57 (12.6) |
| Prior surgery | |
| No | 201 (47.8) |
| Yes | 237 (52.2) |
| Current cancer therapy | |
| Palliative care | 183 (40.3) |
| Anticancer therapy | 271 (59.7) |
| Current drug therapy for symptoms | |
| No | 339 (74.7) |
| Yes | 115 (25.3) |
| Current psychiatric drug | |
| No | 442 (97.4) |
| Yes | 12 (2.6) |
| Anxiety | |
| No | 335 (73.8) |
| Yes | 119 (26.2) |
| Depression | |
| No | 317 (69.8) |
| Yes | 137 (30.2) |
| Anxiety, mean (SD) | 5.60 (4.09) |
| Depression, mean (SD) | 5.92 (4.02) |
| Symptom burden, mean (SD) | 24.82 (21.07) |
Abbreviations: ECOG PS, Eastern Cooperative Oncology Group performance status; SD, standard deviation.